FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks

The benefits of an opioid painkiller linked to a 2015 HIV outbreak in Indiana no longer outweigh the risks, a panel of advisers to the U.S. Food and Drug Administration concluded Tuesday.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news